Antilipaemic drugs and nephrotic hyperlipidaemia.
D000475:Alkenes; D000818:Animals; D001796:Blood Protein Disorders; D001798:Blood Proteins / Q000378:metabolism; D002087:Butyrates; D002994:Clofibrate; D006801:Humans; D006937:Hypercholesterolemia; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D000960:Hypolipidemic Agents; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D010743:Phospholipids / Q000097:blood; D013974:Thyroxine; D014364:Tryptophan
D000475:Alkenes; D001798:Blood Proteins; D002087:Butyrates; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D014364:Tryptophan; D002994:Clofibrate; D013974:Thyroxine